Per Øyvind Enger

Professor
ved Institutt for biomedisin ved Universitetet i Bergen
Overlege / forsker
ved Nevroklinikken ved Helse Bergen HF - Haukeland universitetssykehus

Resultater Resultater

NCT04205357 – a phase I trial investigating Sulfasalazine as radiosensitizer in combination with Gamma Knife Radiosurgery for recurrent Glioblastoma and a Study protocol for a multicenter phase 2/3 trial. .

Skeie, Bente Sandvei; Bragstad, Sidsel Marit; PhD, Dorota Goplen, MD,; Heggdal, Jan Ingemann; Enger, Per Øyvind. 2023, 4th Arctic Stereotactic Conference. HAUKELAND, UIBVitenskapelig foredrag

Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357.

Skeie, Bente Sandvei; Bragstad, Sidsel Marit; PhD, Dorota Goplen, MD,; Heggdal, Jan Ingemann; Enger, Per Øyvind. 2022, The 68th Scandinavian Neurosurgical Congress (SNS). HAUKELAND, UIBVitenskapelig foredrag

Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357.

Skeie, Bente Sandvei; Bragstad, Sidsel Marit; PhD, Dorota Goplen, MD,; Heggdal, Jan Ingemann; Enger, Per Øyvind. 2022, 15th International stereotactic radiosurgery society congress (ISRS). HAUKELAND, UIBVitenskapelig foredrag

Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357.

Skeie, Bente Sandvei; Bragstad, Sidsel Marit; Goplen, Dorota Katarzyna Pazdyk; Heggdal, Jan Ingemann; Enger, Per Øyvind. 2022, 16th Asian Australasian Congress of Neurological Surgeons (AACNS). HAUKELAND, UIBVitenskapelig foredrag

Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357.

Skeie, Bente Sandvei; Bragstad, Sidsel Marit; Sarowar, Shahin; PhD, Dorota Goplen, MD,; Heggdal, Jan; Enger, Per Øyvind. 2022, Society of Neuro-Oncology (SNO) Meeting 2022. HAUKELAND, UIBVitenskapelig foredrag

1 - 5 av 119 | Neste | Siste »